NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
17 Abril 2023 - 3:05PM
NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device
company focused on transforming the lives of people living with
epilepsy, today announced it will report financial results for the
first quarter of 2023 after market close on Thursday, May 4, 2023.
The company’s management will webcast a corresponding conference
call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the
conference call may do so by accessing a live and archived webcast
of the event at www.neuropace.com, on the Investors page in the
News & Events section. The webcast will be available for replay
for at least 90 days after the event.
About NeuroPace, Inc. Based in
Mountain View, Calif., NeuroPace is a commercial-stage medical
device company focused on transforming the lives of people living
with epilepsy by reducing or eliminating the occurrence of
debilitating seizures. Its novel and differentiated RNS System is
the first and only commercially available, brain-responsive
platform that delivers personalized, real-time treatment at the
seizure source. This platform can drive a better standard of care
for patients living with drug-resistant epilepsy and has the
potential to offer a more personalized solution and improved
outcomes to the large population of patients suffering from other
brain disorders.
Investor Contact:Gilmartin
GroupPhilip Trip Taylorinvestors@neuropace.com
Neuropace (NASDAQ:NPCE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Neuropace (NASDAQ:NPCE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024